Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04414475
Title A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM, and Seli and Pomalidomide + LDD in Relapsed Refractory MM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Karyopharm Therapeutics Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries ISR | GRC

Facility Status City State Zip Country Details
University General Hospital of Patras COMPLETED Patra Achaia 2654 Greece Details
General Hospital of Athens "ALEXANDRA" RECRUITING Attiki Athens 11528 Greece Details
General Hospital of Athens "Evaggelismos" RECRUITING Athens Attiki 10676 Greece Details
Theageneion Cancer Hospital RECRUITING Thessaloniki 54007 Greece Details
Emek Medical Center RECRUITING Afula 1834111 Israel Details
Assuta Ashdod Medical Center RECRUITING Ashdod 7747629 Israel Details
Barzilai Medical Center RECRUITING Ashkelon 7830604 Israel Details
Soroka University Medical Center ACTIVE_NOT_RECRUITING Beer-Sheva Israel Details
Bnai-Zion Medical Center RECRUITING Haifa 3108 Israel Details
Rambam Health Care Campus RECRUITING Haifa 3109601 Israel Details
Shaare Zedek Medical Center RECRUITING Jerusalem 9103102 Israel Details
Hadassah Medical Center RECRUITING Jerusalem 9112001 Israel Details
Meir Medical Center COMPLETED Kfar Saba 4428164 Israel Details
Rabin Medical Center (Beilinson Hospital) RECRUITING Petah Tikva 49100 Israel Details
The Chaim Sheba Medical Center at Tel HaShomer RECRUITING Ramat Gan 52621 Israel Details
Tel Aviv Sourasky Medical Center RECRUITING Tel Aviv 64239 Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field